Targeting IRAK1 in T-Cell acute lymphoblastic leukemia
T-cell acute lymphoblastic leukemia (T-ALL) represents expansion of cells arrested at specific stages of thymic development with the underlying genetic abnormality often determining the stage of maturation arrest. Although their outcome has been improved with current therapy, survival rates remain o...
Main Authors: | Dussiau, Charles, Trinquand, Amélie, Lhermitte, Ludovic, Latiri, Mehdi, Simonin, Mathieu, Cieslak, Agata, Bedjaoui, Nawel, Villarèse, Patrick, Verhoeyen, Els, Dombret, Hervé, Ifrah, Norbert, Macintyre, Elizabeth, Asnafi, Vahid |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662467/ |
Similar Items
-
RUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangement
by: Cieslak, Agata, et al.
Published: (2014) -
RUNX1-dependent RAG1 deposition instigates human TCR-δ locus rearrangement
by: Cieslak, Agata, et al.
Published: (2014) -
RUNX1 as a recombinase cofactor
by: Cieslak, Agata, et al.
Published: (2015) -
Outgrowing IRAK-4
by: Bashyam, Hema
Published: (2007) -
IRAK-4 Inhibitors for Inflammation
by: Wang, Zhulun, et al.
Published: (2009)